Rep. Jefferson Shreve sold Alnylam Pharmaceuticals (ALNY)
Rep. Jefferson Shreve (R-IN-6) · $15K–$50K · traded May 12, 2025
- Transaction
- Sold
- Amount
- $15K–$50K
- Owner
- Not stated
- Traded
- May 12, 2025
- Disclosed
- Jun 22, 2025
- Days to disclose
- 41
- Asset type
- Stock
- As filed
- Alnylam Pharmaceuticals, Inc. - Common Stock
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Shreve's trades →- Jun 22, 2025$1K–$15K
Sold Ohio St Wtr Dev Auth Wtr Pollution Ctl Rev 5.000 2032-06-01
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold Ohio St Spl Oblig 5.0000 2029-04-01
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Comcast 6.50% maturing 11/15/35
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold New York NY 5.0000 2033-08-01
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold Denton Tex Indpt Sch Dist 5.0000 2029-08-15
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold Denton Cnty Tex 4.0000 2029-07-15
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Fort Bend Tex Indpt Sch Dist 5.00 2027-8-15/ 346843KW4
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$50K–$100K
Sold Corpus Christi Tex Indpt Sch Dist 4.000 2028-08-15
$50K–$100K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold District Columbia Income Tax Rev 5.000 2032-03-01
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold Sherman Tex 5.0000 2025-08-15
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Pierce Cnty Wash Dist No 010 Tacoma 5.000 2025-12-01
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Omaha Pub Pwr Dist Neb Elec Rev 5.0000 2027-02-01
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Minnesota ST 5.00 2025-08-01
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Kansas City MO 4.0000 2030-02-01
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Wells Fargo 5.574 07/25/29 '28 Mtn
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold Connecticut St Spl Tax Oblig Rev 5.00 2032-5-1/ 207758ZUO
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$50K–$100K
Sold Wells Fargo 6.491 10/23/34 '33 MTN
$50K–$100K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Oregon St 5.0000 2028-12-01
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Sold Grand Praire Tex 5.0000 2032-02-15
$15K–$50K · Traded May 13, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$1K–$15K
Sold Denton Tex 5.0000 2029-02-15
$1K–$15K · Traded May 13, 2025 · disclosed Jun 22, 2025
Recent Congress trades in ALNY
- Sep 9, 2026$1K–$15K
Sen. Cory A. Booker (D-NJ)
Sold (full) Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Aug 11, 2026 · disclosed Sep 9, 2026 · Spouse
- Feb 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Jan 29, 2024 · disclosed Feb 15, 2024 · Joint
- Feb 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Jan 11, 2024 · disclosed Feb 15, 2024 · Joint
- Jan 7, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Alnylam Pharmaceuticals ALNY
$1K–$15K · Traded Dec 11, 2023 · disclosed Jan 7, 2024 · Joint
- Apr 17, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Bought Alnylam Pharmaceuticals ALNY
$15K–$50K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Alnylam Pharmaceuticals ALNY
$15K–$50K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
Company context for ALNY
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
ALNY: Leadership change · Other company developments
Filed 8-K for an event or period dated 2026-11-02. Leadership change; Other company developments.
ALNY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
ALNY: Financial results
Filed 8-K for an event or period dated 2026-10-29. Financial results.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.